Quantcast
Last updated on April 21, 2014 at 10:18 EDT

Latest Drug delivery Stories

2013-12-03 08:31:23

Swiss Army Knife of Interventional Catheters Heralds New Era in Drug Delivery SAUSALITO, Calif., Dec. 3, 2013 /PRNewswire/ -- Sanovas, Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies announced today that the United States Patent and Trademark Office issued patent # 8,597,239 for the company's Abrading Balloon Catheter for Extravasated Drug Delivery....

2013-12-02 20:22:08

YORK, Pa., Dec. 2, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS) today announced an agreement with Novartis to supply clinical products from one of its platforms of injectable drug delivery systems for use with one of Novartis' targeted early-stage pipeline drugs. Under this agreement, Unilife will supply Novartis with a customized delivery device, consisting of syringe, needle, tubing, controller and pump, to enable administration of a...

2013-11-19 12:29:31

BETHLEHEM, Pa., Nov. 19, 2013 /PRNewswire/ -- Particle Sciences, a drug delivery Contract Development and Manufacturing Organization (CDMO), has been contracted by BHR Pharma to develop an in-field nasally applied formulation of Progesterone for traumatic brain injury (TBI). BHR is pioneering this treatment and is well into their study, SyNAPSe® (Study of the Neuroprotective Activity of Progesterone in Severe Traumatic Brain Injuries), a global, Phase 3, multi-center pivotal trial...

2013-11-19 04:21:47

DUBLIN, Nov. 19, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/8k9rtc/pointofdelivery) has announced the addition of the "Point-of-Delivery Drug Reconstitution Systems to 2017" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Growth in the number of injectable drugs supplied in solid form for reconstitution prior to administration is being driven by the increase in drugs based on biological NCEs. These drugs are...

2013-11-11 12:26:28

YORK, Pa., Nov. 11, 2013 /PRNewswire/ -- Unilife Corporation (NASDAQ: UNIS, ASX: UNS), a U.S. based designer, developer and manufacturer of injectable drug delivery systems, today announced an agreement with MedImmune, the global biologics research and development arm of AstraZeneca, to customize and supply devices from its platform of wearable injectors for use with molecules in MedImmune's pipeline. Under this agreement, Unilife will supply MedImmune with customized devices from...

2013-11-08 23:03:36

Reportbuyer.com just published a new market research report: Medical Disposables Market (Drug Delivery, Wound Management Products, Non-Woven Medical Disposables) - Global And U.S. Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018. London (PRWEB) November 08, 2013 The global medical disposables market deals with the market estimation for disposable medical products used in medical procedures. The market is majorly driven by the shift of patient and practitioner focus...

2013-11-07 23:02:10

Catalent Introduces “Patent Pending” FormProRx™ to Solve Formulation Challenges at AAPS. Somerset, NJ (PRWEB) November 07, 2013 Catalent Pharma Solutions, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, today announced that it is to launch its new ‘FormProRx’ web tool on November 11th, during the forthcoming 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition....

2013-11-04 16:26:22

DUBLIN, November 4, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/d8qj9s/european) has announced the addition of the "European Injectable Drug Delivery - Market Forecasts to 2017" [http://www.researchandmarkets.com/research/d8qj9s/european ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) European Injectable Drug Delivery Market By Formulations [Liposomes, Microspheres, &...

2013-11-01 08:26:46

Understanding user needs is critical to improved patient outcomes EXTON, Pa., Nov. 1, 2013 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has completed primary user research with its partner, Insight Product Development, aimed at understanding the needs of patients, caregivers and clinicians in the field of injectable therapies for chronic diseases. West will co-present a poster summarizing...

2013-10-29 08:31:06

New Scientific Method Delivers Diagnostic & Therapeutic Agents Directly to Target Tissues SAUSALITO, Calif., Oct. 29, 2013 /PRNewswire/ -- Sanovas Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office issued patent # 8,540,667 for the company's Multi-Balloon Catheter for Extravasated Drug...